Effects of liraglutide versus placebo on cardiovascular events in patients with type 2 diabetes mellitus and chronic kidney disease: Results from the LEADER trial
No safety guarantees : Because the drug is still investigational, long-term effects are still under study
1 A review article of multiple randomized controlled trials reports an average weight loss of around 16% among users, with some losing as much as 17.4%
Footnote 2: See chart of most played hits at Most Played Hits on Spotify (1990 - 1999)
Whole cereal and legume seeds increase faecal short chain fatty acids compared to ground seeds
The FDA has warned about unapproved GLP-1 products sold online and has noted concerns that illegally marketed products may be counterfeit, may contain incorrect or harmful ingredients, or may contain too little, too much, or none of the claimed active ingredients